ELV logo

Elevance Health (ELV) Free cash flow

annual FCF:

$4.55B-$2.21B(-32.71%)
December 31, 2024

Summary

  • As of today (May 21, 2025), ELV annual free cash flow is $4.55 billion, with the most recent change of -$2.21 billion (-32.71%) on December 31, 2024.
  • During the last 3 years, ELV annual FCF has fallen by -$2.73 billion (-37.45%).
  • ELV annual FCF is now -52.91% below its all-time high of $9.67 billion, reached on December 31, 2020.

Performance

ELV Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVcash flow metrics

quarterly FCF:

$821.00M+$437.00M(+113.80%)
March 31, 2025

Summary

  • As of today (May 21, 2025), ELV quarterly free cash flow is $821.00 million, with the most recent change of +$437.00 million (+113.80%) on March 31, 2025.
  • Over the past year, ELV quarterly FCF has dropped by -$878.00 million (-51.68%).
  • ELV quarterly FCF is now -86.69% below its all-time high of $6.17 billion, reached on March 31, 2023.

Performance

ELV quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVcash flow metrics

TTM FCF:

$3.67B-$878.00M(-19.29%)
March 31, 2025

Summary

  • As of today (May 21, 2025), ELV TTM free cash flow is $3.67 billion, with the most recent change of -$878.00 million (-19.29%) on March 31, 2025.
  • Over the past year, ELV TTM FCF has increased by +$1.38 billion (+60.02%).
  • ELV TTM FCF is now -66.98% below its all-time high of $11.13 billion, reached on March 31, 2023.

Performance

ELV TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

ELV Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-32.7%-51.7%+60.0%
3 y3 years-37.5%-64.1%-49.4%
5 y5 years-8.7%-64.5%-37.7%

ELV Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-37.5%at low-86.7%+124.9%-67.0%+348.1%
5 y5-year-52.9%at low-86.7%+124.9%-67.0%+348.1%
alltimeall time-52.9%+679.2%-86.7%+124.9%-67.0%+2264.2%

ELV Free cash flow History

DateAnnualQuarterlyTTM
Mar 2025
-
$821.00M(+113.8%)
$3.67B(-19.3%)
Dec 2024
$4.55B(-32.7%)
$384.00M(-83.6%)
$4.55B(+422.6%)
Sep 2024
-
$2.35B(+1791.1%)
$871.00M(+6.2%)
Jun 2024
-
$124.00M(-92.7%)
$820.00M(-64.3%)
Mar 2024
-
$1.70B(-151.5%)
$2.30B(-66.1%)
Dec 2023
$6.76B(-6.7%)
-$3.30B(-243.7%)
$6.76B(-18.0%)
Sep 2023
-
$2.29B(+43.4%)
$8.25B(-22.0%)
Jun 2023
-
$1.60B(-74.1%)
$10.57B(-5.0%)
Mar 2023
-
$6.17B(-439.6%)
$11.13B(+53.6%)
Dec 2022
$7.25B(-0.4%)
-$1.82B(-139.3%)
$7.25B(-30.3%)
Sep 2022
-
$4.62B(+114.1%)
$10.39B(+29.6%)
Jun 2022
-
$2.16B(-5.7%)
$8.02B(+10.5%)
Mar 2022
-
$2.29B(+71.7%)
$7.26B(-0.2%)
Dec 2021
$7.28B(-24.7%)
$1.33B(-40.7%)
$7.28B(-23.2%)
Sep 2021
-
$2.25B(+60.7%)
$9.48B(+64.1%)
Jun 2021
-
$1.40B(-39.2%)
$5.78B(-40.2%)
Mar 2021
-
$2.30B(-34.9%)
$9.66B(-0.1%)
Dec 2020
$9.67B(+94.0%)
$3.54B(-342.8%)
$9.67B(+36.0%)
Sep 2020
-
-$1.46B(-127.6%)
$7.11B(-28.6%)
Jun 2020
-
$5.28B(+128.3%)
$9.96B(+68.8%)
Mar 2020
-
$2.31B(+136.8%)
$5.90B(+18.4%)
Dec 2019
$4.98B(+90.3%)
$976.00M(-30.1%)
$4.98B(+20.1%)
Sep 2019
-
$1.40B(+14.8%)
$4.15B(+38.0%)
Jun 2019
-
$1.22B(-12.9%)
$3.01B(+49.0%)
Mar 2019
-
$1.40B(+876.2%)
$2.02B(-22.9%)
Dec 2018
$2.62B(-22.8%)
$143.00M(-43.3%)
$2.62B(+191.0%)
Sep 2018
-
$252.00M(+11.0%)
$900.00M(-68.2%)
Jun 2018
-
$227.00M(-88.6%)
$2.83B(+0.1%)
Mar 2018
-
$2.00B(-226.7%)
$2.83B(-16.6%)
Dec 2017
$3.39B(+26.4%)
-$1.58B(-172.1%)
$3.39B(-33.2%)
Sep 2017
-
$2.19B(+878.2%)
$5.08B(+37.6%)
Jun 2017
-
$223.50M(-91.3%)
$3.69B(-7.8%)
Mar 2017
-
$2.56B(+2266.3%)
$4.00B(+49.1%)
Dec 2016
$2.69B(-24.8%)
$108.20M(-86.5%)
$2.69B(-20.8%)
Sep 2016
-
$799.60M(+49.2%)
$3.39B(+23.0%)
Jun 2016
-
$535.90M(-56.9%)
$2.76B(-15.2%)
Mar 2016
-
$1.24B(+52.4%)
$3.25B(-8.9%)
Dec 2015
$3.57B(+34.6%)
$815.10M(+394.6%)
$3.57B(+29.5%)
Sep 2015
-
$164.80M(-84.0%)
$2.76B(-9.8%)
Jun 2015
-
$1.03B(-33.9%)
$3.06B(+3.3%)
Mar 2015
-
$1.56B(>+9900.0%)
$2.96B(+11.7%)
Dec 2014
$2.65B(+10.3%)
$1.10M(-99.8%)
$2.65B(-1.2%)
Sep 2014
-
$466.30M(-50.2%)
$2.69B(-22.3%)
Jun 2014
-
$935.50M(-25.3%)
$3.46B(+23.2%)
Mar 2014
-
$1.25B(+3539.0%)
$2.81B(+16.7%)
Dec 2013
$2.41B
$34.40M(-97.2%)
$2.41B(-18.8%)
Sep 2013
-
$1.24B(+337.4%)
$2.96B(+63.3%)
DateAnnualQuarterlyTTM
Jun 2013
-
$283.20M(-66.7%)
$1.81B(-7.0%)
Mar 2013
-
$849.40M(+44.0%)
$1.95B(-11.4%)
Dec 2012
$2.20B(-23.0%)
$590.00M(+547.6%)
$2.20B(+48.4%)
Sep 2012
-
$91.10M(-78.3%)
$1.48B(-45.0%)
Jun 2012
-
$419.30M(-61.9%)
$2.69B(-8.4%)
Mar 2012
-
$1.10B(-964.2%)
$2.94B(+3.0%)
Dec 2011
$2.85B(+195.8%)
-$127.20M(-109.8%)
$2.85B(-17.3%)
Sep 2011
-
$1.30B(+95.2%)
$3.45B(+17.6%)
Jun 2011
-
$667.10M(-34.1%)
$2.94B(+21.2%)
Mar 2011
-
$1.01B(+115.9%)
$2.42B(+150.8%)
Dec 2010
$965.30M(-63.7%)
$469.20M(-40.3%)
$965.30M(+130.0%)
Sep 2010
-
$785.70M(+411.9%)
$419.70M(-56.2%)
Jun 2010
-
$153.50M(-134.6%)
$959.20M(-12.3%)
Mar 2010
-
-$443.10M(+480.0%)
$1.09B(-58.9%)
Dec 2009
$2.66B(+21.5%)
-$76.40M(-105.8%)
$2.66B(-14.3%)
Sep 2009
-
$1.33B(+359.2%)
$3.10B(+19.5%)
Jun 2009
-
$288.60M(-74.3%)
$2.60B(+10.5%)
Mar 2009
-
$1.12B(+205.4%)
$2.35B(+7.3%)
Dec 2008
$2.19B(-45.6%)
$367.80M(-55.1%)
$2.19B(-22.2%)
Sep 2008
-
$818.60M(+1886.9%)
$2.82B(+15.4%)
Jun 2008
-
$41.20M(-95.7%)
$2.44B(-20.3%)
Mar 2008
-
$962.20M(-3.2%)
$3.06B(-23.9%)
Dec 2007
$4.02B(+4.5%)
$993.80M(+124.9%)
$4.02B(-8.5%)
Sep 2007
-
$441.90M(-33.3%)
$4.40B(-2.7%)
Jun 2007
-
$662.40M(-65.6%)
$4.52B(+12.5%)
Mar 2007
-
$1.92B(+40.7%)
$4.01B(+4.2%)
Dec 2006
$3.85B(+24.4%)
$1.37B(+143.5%)
$3.85B(+14.0%)
Sep 2006
-
$561.60M(+251.0%)
$3.38B(-3.8%)
Jun 2006
-
$160.00M(-90.9%)
$3.51B(-11.4%)
Mar 2006
-
$1.76B(+97.2%)
$3.96B(+28.0%)
Dec 2005
$3.09B(+165.3%)
$893.30M(+28.4%)
$3.09B(+12.0%)
Sep 2005
-
$695.90M(+13.8%)
$2.76B(+13.0%)
Jun 2005
-
$611.40M(-31.6%)
$2.44B(+37.7%)
Mar 2005
-
$894.30M(+59.2%)
$1.77B(+52.2%)
Dec 2004
$1.17B(+12.9%)
$561.60M(+48.8%)
$1.17B(+17.2%)
Sep 2004
-
$377.30M(-746.1%)
$994.90M(+8.1%)
Jun 2004
-
-$58.40M(-120.4%)
$920.00M(-15.3%)
Mar 2004
-
$285.90M(-26.7%)
$1.09B(+5.2%)
Dec 2003
$1.03B(+19.0%)
$390.10M(+29.0%)
$1.03B(+6.7%)
Sep 2003
-
$302.40M(+180.3%)
$968.20M(-3.9%)
Jun 2003
-
$107.90M(-53.6%)
$1.01B(+6.6%)
Mar 2003
-
$232.30M(-28.7%)
$944.70M(+8.9%)
Dec 2002
$867.80M(+48.5%)
$325.60M(-4.7%)
$867.80M(+60.1%)
Sep 2002
-
$341.70M(+657.6%)
$542.20M(+170.4%)
Jun 2002
-
$45.10M(-71.0%)
$200.50M(+29.0%)
Mar 2002
-
$155.40M
$155.40M
Dec 2001
$584.20M
-
-

FAQ

  • What is Elevance Health annual free cash flow?
  • What is the all time high annual FCF for Elevance Health?
  • What is Elevance Health annual FCF year-on-year change?
  • What is Elevance Health quarterly free cash flow?
  • What is the all time high quarterly FCF for Elevance Health?
  • What is Elevance Health quarterly FCF year-on-year change?
  • What is Elevance Health TTM free cash flow?
  • What is the all time high TTM FCF for Elevance Health?
  • What is Elevance Health TTM FCF year-on-year change?

What is Elevance Health annual free cash flow?

The current annual FCF of ELV is $4.55B

What is the all time high annual FCF for Elevance Health?

Elevance Health all-time high annual free cash flow is $9.67B

What is Elevance Health annual FCF year-on-year change?

Over the past year, ELV annual free cash flow has changed by -$2.21B (-32.71%)

What is Elevance Health quarterly free cash flow?

The current quarterly FCF of ELV is $821.00M

What is the all time high quarterly FCF for Elevance Health?

Elevance Health all-time high quarterly free cash flow is $6.17B

What is Elevance Health quarterly FCF year-on-year change?

Over the past year, ELV quarterly free cash flow has changed by -$878.00M (-51.68%)

What is Elevance Health TTM free cash flow?

The current TTM FCF of ELV is $3.67B

What is the all time high TTM FCF for Elevance Health?

Elevance Health all-time high TTM free cash flow is $11.13B

What is Elevance Health TTM FCF year-on-year change?

Over the past year, ELV TTM free cash flow has changed by +$1.38B (+60.02%)
On this page